Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 270

1.

The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.

Floege J, Kubo Y, Floege A, Chertow GM, Parfrey PS.

Clin J Am Soc Nephrol. 2015 Apr 17. pii: CJN.10221014. [Epub ahead of print]

PMID:
25887067
2.

Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.

Kubo Y, Sterling LR, Parfrey PS, Gill K, Mahaffey KW, Gioni I, Trotman ML, Dehmel B, Chertow GM.

Pharm Stat. 2015 Apr 6. doi: 10.1002/pst.1680. [Epub ahead of print]

PMID:
25851955
3.

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; for the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators.

Clin J Am Soc Nephrol. 2015 Feb 20. pii: CJN.07730814. [Epub ahead of print]

PMID:
25710802
4.

Clinical genetic research 1: Bias.

Stuckless S, Parfrey PS.

Methods Mol Biol. 2015;1281:333-48. doi: 10.1007/978-1-4939-2428-8_20.

PMID:
25694320
5.

Randomized controlled trials: planning, monitoring, and execution.

Hatfield E, Dicks E, Parfrey PS.

Methods Mol Biol. 2015;1281:273-86. doi: 10.1007/978-1-4939-2428-8_16.

PMID:
25694316
6.

Randomized controlled trials 7: Analysis and interpretation of quality-of-life scores.

Foley RN, Parfrey PS.

Methods Mol Biol. 2015;1281:261-72. doi: 10.1007/978-1-4939-2428-8_15.

PMID:
25694315
7.

Randomized controlled trials 6: On contamination and estimating the actual treatment effect.

Parfrey PS.

Methods Mol Biol. 2015;1281:249-59. doi: 10.1007/978-1-4939-2428-8_14.

PMID:
25694314
8.

Randomized controlled trials 1: Design.

Curtis BM, Barrett BJ, Parfrey PS.

Methods Mol Biol. 2015;1281:159-75. doi: 10.1007/978-1-4939-2428-8_9.

PMID:
25694309
9.

Longitudinal studies 3: Data modeling using standard regression models and extensions.

Ravani P, Barrett BJ, Parfrey PS.

Methods Mol Biol. 2015;1281:93-131. doi: 10.1007/978-1-4939-2428-8_6.

PMID:
25694306
10.

Longitudinal studies 2: Modeling data using multivariate analysis.

Ravani P, Barrett BJ, Parfrey PS.

Methods Mol Biol. 2015;1281:71-92. doi: 10.1007/978-1-4939-2428-8_5.

PMID:
25694305
11.

On framing the research question and choosing the appropriate research design.

Parfrey PS, Ravani P.

Methods Mol Biol. 2015;1281:3-18. doi: 10.1007/978-1-4939-2428-8_1.

PMID:
25694301
12.

Dietary patterns and colorectal cancer: results from a Canadian population-based study.

Chen Z, Wang PP, Woodrow J, Zhu Y, Roebothan B, Mclaughlin JR, Parfrey PS.

Nutr J. 2015 Jan 15;14:8. doi: 10.1186/1475-2891-14-8.

13.

Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.

Moe SM, Abdalla S, Chertow GM, Parfrey PS, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Dehmel B, Goodman WG, Drüeke TB; for the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators.

J Am Soc Nephrol. 2014 Dec 11. pii: ASN.2014040414. [Epub ahead of print]

PMID:
25505257
14.

Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.

Wheeler DC, London GM, Parfrey PS, Block GA, Correa-Rotter R, Dehmel B, Drüeke TB, Floege J, Kubo Y, Mahaffey KW, Goodman WG, Moe SM, Trotman ML, Abdalla S, Chertow GM, Herzog CA; EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial Investigators.

J Am Heart Assoc. 2014 Nov 17;3(6):e001363. doi: 10.1161/JAHA.114.001363.

15.

Responsiveness of the patient's perception of hemodialysis scale.

Twomey JC, Parfrey PS, Barrett BJ, Churchill DN, Way CY.

CANNT J. 2014 Apr-Jun;24(2):33-44.

PMID:
25276989
16.

Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype.

Zhu Y, Yang SR, Wang PP, Savas S, Wish T, Zhao J, Green R, Woods M, Sun Z, Roebothan B, Squires J, Buehler S, Dicks E, Zhao J, Mclaughlin JR, Parfrey PS, Campbell PT.

Br J Cancer. 2014 Mar 4;110(5):1359-66. doi: 10.1038/bjc.2014.6. Epub 2014 Jan 21.

17.

Dietary N-nitroso compounds and risk of colorectal cancer: a case-control study in Newfoundland and Labrador and Ontario, Canada.

Zhu Y, Wang PP, Zhao J, Green R, Sun Z, Roebothan B, Squires J, Buehler S, Dicks E, Zhao J, Cotterchio M, Campbell PT, Jain M, Parfrey PS, Mclaughlin JR.

Br J Nutr. 2014 Mar 28;111(6):1109-17. doi: 10.1017/S0007114513003462. Epub 2013 Oct 25.

18.

The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial.

Parfrey PS, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Dehmel B, Trotman ML, Modafferi DM, Goodman WG.

J Clin Endocrinol Metab. 2013 Dec;98(12):4834-44. doi: 10.1210/jc.2013-2975. Epub 2013 Oct 9.

PMID:
24108314
19.

On peginesatide and anemia treatment in CKD.

Parfrey PS, Warden G, Barrett BJ.

Am J Kidney Dis. 2013 Oct;62(4):659-61. doi: 10.1053/j.ajkd.2013.05.008. Epub 2013 Jun 28. No abstract available.

PMID:
23810692
20.

Cinacalcet for cardiovascular disease in patients undergoing dialysis.

Chertow GM, Parfrey PS.

N Engl J Med. 2013 May 9;368(19):1844-5. doi: 10.1056/NEJMc1301247. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk